The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors

Authors: Bianca Balbino, Pauline Herviou, Ophélie Godon, Julien Stackowicz, Odile Richard-Le Goff, Bruno Iannascoli, Delphine Sterlin, Sébastien Brûlé, Gael A. Millot, Faith M. Harris, Vera A. Voronina, Kari C. Nadeau, Lynn E. Macdonald, Andrew J. Murphy, Pierre Bruhns, Laurent L. Reber

Published: 2019-11-26

DOI: 10.1172/jci129697

Source: Full article


Abstract

No abstract found.